← Every company
Novo Nordisk A/S Lobbying
What Novo Nordisk A/S discloses spending to lobby Congress, and who it pays to do it. Every lobbying firm files quarterly under the Lobbying Disclosure Act, naming its client, its fee and the issues it worked.
NVO on carbonthat →Disclosed spend
$3.9M
across every filing on file
Filings
25
Years covered
1
Firms retained
4
What it lobbies about
Health IssuesBudget/AppropriationsMedicare/MedicaidTaxation/Internal Revenue CodeCopyright/Patent/TrademarkTrade (domestic/foreign)
25 filings
Newest year first, and within a year the largest fee first — a filing period is a word rather than a date, so it cannot order itself.
| Period | Lobbying for them | Disclosed |
|---|---|---|
| 20262nd Quarter (Apr 1 - June 30) | NOVO NORDISK INC.Health IssuesBudget/Appropriations | $1.3M |
| 20261st Quarter (Jan 1 - Mar 31) | NOVO NORDISK INC.Health IssuesBudget/Appropriations | $1.3M |
| 20262nd Quarter (Apr 1 - June 30) | BALLARD PARTNERSPharmacy | $120K |
| 20261st Quarter (Jan 1 - Mar 31) | BALLARD PARTNERSPharmacy | $120K |
| 20261st Quarter (Jan 1 - Mar 31) | CHECKMATE GOVERNMENT RELATIONSHealth Issues | $90K |
| 20262nd Quarter (Apr 1 - June 30) | CHECKMATE GOVERNMENT RELATIONSHealth Issues | $90K |
| 20261st Quarter (Jan 1 - Mar 31) | THE NICKLES GROUP, LLCHealth IssuesMedicare/Medicaid | $80K |
| 20261st Quarter (Jan 1 - Mar 31) | ARNOLD & PORTER KAYE SCHOLER LLPPharmacyHealth Issues | $80K |
| 20262nd Quarter (Apr 1 - June 30) | THE NICKLES GROUP, LLCHealth IssuesMedicare/Medicaid | $80K |
| 20261st Quarter (Jan 1 - Mar 31) | NVG, LLCMedicare/MedicaidHealth Issues | $80K |
| 20262nd Quarter (Apr 1 - June 30) | ARNOLD & PORTER KAYE SCHOLER LLPHealth IssuesMedicare/Medicaid | $70K |
| 20261st Quarter (Jan 1 - Mar 31) | TARPLIN, DOWNS & YOUNG, LLCHealth IssuesMedicare/Medicaid | $60K |
| 20262nd Quarter (Apr 1 - June 30) | TARPLIN, DOWNS & YOUNG, LLCHealth IssuesMedicare/Medicaid | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | WILLIAMS AND JENSEN, PLLCHealth IssuesBudget/Appropriations | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | HOLLAND & KNIGHT LLPBudget/AppropriationsHealth Issues | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | TODD STRATEGY GROUPHealth Issues | $60K |
| 20262nd Quarter (Apr 1 - June 30) | HOLLAND & KNIGHT LLPBudget/AppropriationsHealth Issues | $60K |
| 20262nd Quarter (Apr 1 - June 30) | WILLIAMS AND JENSEN, PLLCHealth IssuesBudget/Appropriations | $60K |
| 20262nd Quarter (Apr 1 - June 30) | S-3 GROUPHealth IssuesMedicare/Medicaid | $20K |
| 20261st Quarter (Jan 1 - Mar 31) | S-3 GROUPHealth IssuesMedicare/Medicaid | $20K |
| 20261st Quarter (Jan 1 - Mar 31) | AVOQ, LLCHealth Issues | $20K |
| 20261st Quarter (Jan 1 - Mar 31) | PUBLIC STRATEGIES WASHINGTON, INC. | $10K |
| 20261st Quarter (Jan 1 - Mar 31) | S-3 GROUPHealth IssuesMedicare/Medicaid | — |
| 20262nd Quarter (Apr 1 - June 30) | ARNOLD & PORTER KAYE SCHOLER LLP | — |
| 20261st Quarter (Jan 1 - Mar 31) | ARNOLD & PORTER KAYE SCHOLER LLP | — |
A filing reports either the fee paid to a lobbying firm or what a company spent lobbying for itself, never both, so the total is a sum of the two. The client is named as filed, which is often a subsidiary. Lobbying is lawful, disclosed and extremely common — the figure is context, not an accusation.
More on NVO
Company overviewEverything on NVO in one place, with the price.SEC filingsWhat NVO's 8-Ks say happened: results, departures, auditor changes.Who owns itEvery manager reporting a position in NVO.Funds holding itWhich funds and ETFs hold NVO, and how big a bet.Who lobbies for itThe lobbyists on NVO's account, and who they worked for.PatentsWhat NVO is filing at the patent office.